We adopted a stable gene knockdown approach to establish knockdown clones of S100A11 (shS100A11) in PLC/PRF/5 and CLC7 HCC cell lines and confirmed their knockdown efficiency (Figure S4). This evidence concerns the gene S100A11 and hepatocellular carcinoma.